Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 29, 2008
- Accepted October 29, 2008
- Published online January 21, 2009.
Article Versions
- Earlier version (October 29, 2008 - 10:04).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Christopher D. Kane,
- Kimberly A. Stevens,
- James E. Fischer,
- Mehrdad Haghpassand,
- Lori J. Royer,
- Charles Aldinger,
- Katherine T. Landschulz1,
- Panayiotis Zagouras,
- Scott W. Bagley,
- William Hada,
- Robert Dullea,
- Cheryl M. Hayward and
- Omar L. Francone
- Departments of Atherosclerosis Biology (C.D.K., K.A.S., M.H., L.J.R., C.A., K.T.L., O.L.F.), Atherosclerosis Chemistry (S.W.B., W.H., C.M.H.), and Genetic Technologies (J.E.F., P.Z., R.D.), Pfizer Global Research & Development, Pfizer Inc., Groton, Connecticut
- Address correspondence to:
Dr. Christopher D. Kane, Pfizer Global Research and Development, Pfizer Inc., Eastern Point Road, MS 8220-2401, Groton, CT 06340. E-mail: christopher.d.kane{at}pfizer.com